General MedicationsORALStandard
ZESTRIL
LISINOPRIL
Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ZESTRIL is listed in Drugs@FDA under application 019777 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LISINOPRIL Form and strength TABLET;ORAL - 2.5MG Sponsor TWI PHARMS Submission history Latest submission status date: 2017-07-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZESTRIL is listed in Drugs@FDA under application 019777 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LISINOPRIL Form and strength TABLET;ORAL - 2.5MG Sponsor TWI PHARMS Submission history Latest submission status date: 2017-07-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.